Skip to content
Open access

Network-targeted neurophysiological biomarkers of dysconnectivity and cognitive decline in Alzheimer’s disease

Sep 2026 · Alzheimer's Research & Therapy · 0 citations

TL;DR

These network-specific, hemisphere-sensitive measures may serve as biomarkers for diagnosis, tracking, and prognosis of cognitive decline, and could inform personalized network-targeted neuromodulation in AD.

Abstract

Alzheimer’s disease (AD) is marked by progressive network disconnection that begins decades before symptoms emerge, yet detecting early functional disruptions remains a key challenge. Transcranial magnetic stimulation combined with electroencephalography (TMS–EEG) provides a direct, non-invasive probe of cortical dynamics and may yield biomarkers that index cortical network dysfunction, track progression, and inform personalized neuromodulation strategies. We enrolled 86 participants: 28 HC (mean age 69.7 ± 6.0, 15 female), 27 MCI (73.1 ± 5.2, 16 female), and 31 ADD (75.8 ± 4.9, 17 female). TMS–EEG targeted individualized default mode (DMN) and executive control (ECN) network nodes identified via resting-state fMRI. Using a data-driven strategy, we extracted early TMS-evoked potential (TEP) components within 50 ms. We assessed group differences, associations with hippocampal volume, white matter integrity, and cognition, and prediction of cognitive decline over ~ 1.5 years ( n  = 55). After left DMN stimulation, the contralateral frontal N20F peak was increased in both MCI (P-adj. = 0.0001, Δ = 1.89 µV) and ADD (P-adj. = 0.0003, Δ = 1.76 µV) relative to HC, achieving an AUC of 0.82 for HC-versus-MCI classification. In the ECN, N20C amplitude showed a diagnosis-by-hemisphere interaction: reduced in MCI after left stimulation (P-adj. = 0.036, Δ = −13.64 µV) but increased in MCI and ADD after right stimulation (P-adj. = 0.028, Δ = 14.59 µV and P-adj. = 0.048, Δ = 10.30 µV). Left DMN N20C amplitude correlated with superior longitudinal fasciculus integrity ( P  = 0.009, β = 37.15). TEPs were selectively linked to executive function: in ADD, larger left ECN N20F predicted worse Trail Making Test scores (P-adj. = 0.0003, β = −24.35). Longitudinally, lower left DMN N20C predicted steeper global cognitive decline (β = 0.74, P  = 0.014), and right ECN N20C predicted executive decline in MCI (β = −35.15, P  = 0.0004). Early network-targeted TEPs capture functional alterations linked to AD progression. Limitations include the moderate sample size, clinical rather than biomarker-confirmed diagnosis, and single-site design. These network-specific, hemisphere-sensitive measures may serve as biomarkers for diagnosis, tracking, and prognosis of cognitive decline, and could inform personalized network-targeted neuromodulation in AD. Not applicable (observational study).

Read PDF

Similar papers

Open access Oct 2026

A Comparative Study of EEG-Based Nonlinear Effective Connectivity for Classifying Alzheimer’s Disease and Frontotemporal Dementia

The preliminary findings suggest that altered nonlinear EC may be associated with AD and FTD pathophysiology, and highlight EEG-based graph-theoretical features as a promising direction for diagnostic decision-support research, pending validation in larger, independent cohorts.

Noura M. Alotaibi, A. Aleidan · 0 citations
Review Open access Sep 2026

Resting-State EEG Microstate Dynamics as Neurophysiological Biomarkers Across the Alzheimer’s Disease Continuum: A Systematic Review

Electroencephalography microstates, brief periods of quasi-stable large-scale neural synchrony, have emerged as candidate markers of resting-state network disruption and show graded group-level differences across clinically defined SCD, MCI, and AD dementia samples.

Chanda Simfukwe, Seong Soo A. An, Y. Youn · 0 citations
Open access Aug 2026

Target-level convergence of directional prefrontal connectivity across Alzheimer’s disease stages: an fNIRS study

It is suggested that MCI and AD are associated with distinct patterns of directional information flow within prefrontal networks, characterized by reduced convergence toward FPC-R and increased directional influence toward DLPFC-L.

N. Mateen, Rana Muhammad Kaleem Ullah, Jisoo Baik et al. · 0 citations
Open access Sep 2026

519. Baseline EEG connectivity predicts differential clinical response to donepezil and memantine in Alzheimer’s disease

Investigating baseline EEG-based brain connectivity measures in patients with Alzheimer’s disease suggested that altered baseline gamma-band EEG connectivity may reflect underlying differences in cholinergic network integrity and could serve as a potential biomarker for predicting long-term pharmacological treatment re...

T. Youn, J. Eo, H.-J. Park et al. · 0 citations
Open access Sep 2026

Deciphering Physiological and Pathological Influences on Amygdala-Hippocampus Connectivity

These findings suggest that effective connectivity results from the interplay of opposing physiological and pathological influences rather than a simple facilitation within the EZ, and that white matter microstructure independently contributes to this timing.

O. Feys, M. Josyula, Nilu Sinha et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.